ABCELY logo

ABCELY jobs and careers

France

About ABCELY

Abcely's mission is to revolutionize the treatment of mucosal cancers, endometriosis, and inflammatory bowel diseases by pioneering innovative medical and pharmaceutical technologies. With a focus on providing new hope for patients facing therapeutic dead ends, Abcely introduces a groundbreaking concept in immunotherapy. At the heart of this innovation is the use of a novel class of orally active therapeutic molecules: class A immunoglobulins (sIgA). Abcely is committed to advancing these treatments through every stage of development—from identifying active compounds to proving their efficacy in human clinical trials—ensuring a transformative impact on patient care.

Founded
2022
Employees
1 to 10
Total funding
$2.4M
Headquarters
France

Leadership

The top of ABCELY's org chart, with how many people report into each leader.

ACPhoto of Armelle Cuvillier

Armelle Cuvillier

Chief Scientific Officer